Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

SNAKE BITES: A SILENT RISK NOT TO BE UNDERESTIMATED

18/04/2026 Published by vivi

Snake bites are often overlooked in workplace and outdoor safety risks yet in reality, they can become life-threatening within hours... Read more

Tags: #Corporate Wellness

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

18/04/2026 Published by vivi

At the American Association for Cancer Research (AACR) Annual Meeting 2026, Abbott presented new data demonstrating significant advancements in its... Read more

Category: Uncategorized

Tags: #Global Trends

SK Life Science Labs to present new preclinical data on targeted protein degradation at AACR 2026

18/04/2026 Published by vivi

At the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, SK Life Science Labs, a subsidiary... Read more

Category: Uncategorized

Tags: #Global Trends

MSN Laboratories launches Semabest Semaglutide in India to enhance affordability

18/04/2026 Published by vivi

MSN Laboratories has officially introduced Semabest, its domestic semaglutide brand, to the Indian market following approval from the Central Drugs... Read more

Category: Uncategorized

Tags: #Global Trends

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Partner to Advance ADC Manufacturing

18/04/2026 Published by vivi

Piramal Pharma Solutions (India) and Ajinomoto Bio-Pharma Services (Japan) have announced a strategic collaboration to enhance the development and manufacturing... Read more

Category: Uncategorized

Tags: #Global Trends

European Commission approves Merck’s ENFLONSIA™ (clesrovimab) for infant RSV prevention

18/04/2026 Published by vivi

The European Commission (EC) has officially granted marketing authorization for ENFLONSIA™ (clesrovimab), a long-acting monoclonal antibody developed by Merck (MSD)... Read more

Category: Uncategorized

Tags: #Global Trends